Pegus Cheryl

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Pegus Cheryl's trades of Boston Scientific Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Phreesia Inc (PHR)
Transaction date
Sale
Price
326.34
Quantity 47,116 -11.7%
Value US$1,057,902
US Phreesia Inc (PHR)
Transaction date
Sale
Price
66.97
Quantity 76,945 -47.1%
Value US$2,779,515
US Phreesia Inc (PHR)
Transaction date
Sale
Price
18.00
Quantity 280,689 -11.4%
Value US$5,052,402
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-21 2026-05-20
B Purchase
79,994 -49.7%
401.38
US$336,008 		79,994 -49.7% 401.38 US$336,008
2020-12-18 2020-12-17
US Phreesia Inc (PHR)
S Sale
47,116 -11.7%
326.34
US$1,057,902 		47,116 -11.7% 326.34 US$1,057,902
2020-12-18 2020-12-16
US Phreesia Inc (PHR)
S Sale
76,945 -47.1%
66.97
US$2,779,515 		76,945 -47.1% 66.97 US$2,779,515
2019-07-24 2019-07-22
US Phreesia Inc (PHR)
S Sale
280,689 -11.4%
18.00
US$5,052,402 		280,689 -11.4% 18.00 US$5,052,402